Bioactive Peptide Market Size, Share, Growth, Trends, and Global Industry Analysis: By Source (Plant, Milk, Eggs, Meat, Fish, and Others), Therapeutic Area (Anti-Hypertensives, Cardiovascular System, Nervous System, Gastrointestinal System, Antioxidant, Immunostimulatory, Antimicrobial, Diabetes, and Immune System), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Drug Store, and Mail-Order Pharmacy), and Region Forecast 2019 -2030

Bioactive Peptide Market size was valued at USD 2,739.8 million in 2023 and is projected to grow at a CAGR of 8.3% from 2019 - 2030. The bioactive peptides include amino acids linked through a covalent bond. These substances are extracted from different natural sources and are known to provide a wide range of health benefits. They are also used in providing a variety of functions for food and beverage products, which results in less oxidation and degradation. The market for bioactive peptides is expanding rapidly due to rising consumer demand for functional foods and supplements that provide health advantages above and beyond those of a basic diet. A growing understanding of the benefits of bioactive peptides in boosting immunity, controlling metabolic diseases, and raising general well-being are important stimulants. The variety of products and applications that are now available has increased due to developments in peptide synthesis and technology, which has further fueled market expansion. Despite this, the market encounters various limitations, including elevated production expenses and regulatory obstacles concerning the safety and effectiveness of peptides. Personalized nutrition solutions and novel peptide-based treatments present substantial prospects despite these constraints.

Trends are increasing focus on preventive healthcare and integration of peptides within sports nutrition and anti-aging products is going to shape the future direction of the market. Further research and approvals of peptide-based solutions will result in the expansion and diversification of the market. The expansion of these categories will assist you in analyzing the industry's merger growth segments and give users a useful market overview along with company insights that will help in their strategic decision-making for discovering key market applications.

Bioactive Peptide Market Key Developments :

• In January 2022: A new generation of scientifically designed biomimetic peptides was introduced by BASF SE with Peptovitae, a set of four patented peptides. Through a special partnership with Caregen, a Korean business that leads the world in biomimetic peptide research and development, Peptovitae has been developed in Asia.
• In October 2022: According to a joint study by researchers from Stanford University and Hofseth BioCare, the bioactive peptides in ProGo made from salmon help maintain a balanced immune system in the gastrointestinal tract.